GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2701 - 2725 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 3 4 mild
G08520NM
94
IgM Patient 3 4 mild
G14844CX
94
IgM Patient 3 4 mild
G17390SF
94
IgM Patient 3 4 mild
G18057VI
94
IgG Patient 4 12 mild
G00051MO
94
IgG Patient 4 12 mild
G07483YN
94
IgG Patient 4 12 mild
G32473MI
94
IgG Patient 4 12 mild
G47566FL
94
IgM Patient 4 12 mild
G86156UJ
94
IgM Patient 1 22 moderate
G14569AR
93
IgG Patient 2 15 mild
G22768VO
93
IgM Patient 2 3 mild
G84224TW
93
IgM Patient 3 -180 mild
G21460SG
93
IgM Patient 3 -180 mild
G47548GA
93
IgG Patient 3 4 mild
G43534QA
93
IgG Patient 4 12 mild
G02670IJ
93
IgG Patient 4 12 mild
G82348BZ
93
IgM Patient 2 24 mild
G00068MO
92
IgM Patient 2 3 mild
G92823JK
92
IgM Patient 3 -180 mild
G22768VO
92
IgM Patient 3 -180 mild
G52880ZN
92
IgM Patient 3 -180 mild
G92823JK
92
IgM Patient 3 11 mild
G21460SG
92
IgG Patient 4 12 mild
G40696TO
92
IgG Patient 1 22 moderate
G60761LT
91

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024